4.5 Review

Natural Animal Models of Neurodegenerative Protein Misfolding Diseases

Journal

CURRENT PHARMACEUTICAL DESIGN
Volume 18, Issue 8, Pages 1148-1158

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138161212799315768

Keywords

Prion; amyloid; protein misfolding; natural model; non-transgenic; Alzheimer's disease

Funding

  1. [P01 AI777704]

Ask authors/readers for more resources

Neurodegenerative diseases (NDs) are some of the most debilitating human illnesses. Research over the past 10 years has provided evidence for a common mechanism of neurodegeneration in which the critical event is the brain accumulation of misfolded protein aggregates. Although it is well established that misfolded proteins play an important role in these diseases, the mechanisms by which they cause cellular and tissue dysfunction are still unknown. To understand the molecular basis of NDs and to develop therapeutic strategies against them, numerous transgenic rodent models have been produced, which reproduce some (but not all) of the features of these diseases. Importantly, some NDs are not exclusive to human beings, such as transmissible spongiform encephalopathies. Moreover, other diseases which are associated to aging (e.g. Alzheimer's disease) could be studied in aged mammals, which could reproduce the human disease in a more natural way. Although the usefulness of transgenic mice is unquestionable, the information obtained from natural non-transgenic models could be very valuable to fully understand the pathogenesis of these devastating diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neurosciences

Impaired Peripheral Lymphatic Function and Cerebrospinal Fluid Outflow in a Mouse Model of Alzheimer's Disease

Sunkuk Kwon, Ines Moreno-Gonzalez, Kathleen Taylor-Presse, George Edwards, Nazaret Gamez, Olivia Calderon, Banghe Zhu, Fred Christian Velasquez, Claudio Soto, Eva M. Sevick-Muraca

JOURNAL OF ALZHEIMERS DISEASE (2019)

Article Clinical Neurology

Distinct disease-sensitive GABAergic neurons in the perirhinal cortex of Alzheimer's mice and patients

Elisabeth Sanchez-Mejias, Cristina Nunez-Diaz, Raquel Sanchez-Varo, Angela Gomez-Arboledas, Juan Antonio Garcia-Leon, Juan Jose Fernandez-Valenzuela, Marina Mejias-Ortega, Laura Trujillo-Estrada, David Baglietto-Vargas, Ines Moreno-Gonzalez, Jose Carlos Davila, Javier Vitorica, Antonia Gutierrez

BRAIN PATHOLOGY (2020)

Article Biochemistry & Molecular Biology

The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease

Maritza Onate, Alejandra Catenaccio, Natalia Salvadores, Cristian Saquel, Alexis Martinez, Ines Moreno-Gonzalez, Nazaret Gamez, Paulina Soto, Claudio Soto, Claudio Hetz, Felipe A. Court

CELL DEATH AND DIFFERENTIATION (2020)

Correction Biochemistry & Molecular Biology

The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease (vol 32, pg 274, 2019)

Maritza Onate, Alejandra Catenaccio, Natalia Salvadores, Cristian Saquel, Alexis Martinez, Ines Moreno-Gonzalez, Nazaret Gamez, Paulina Soto, Claudio Soto, Claudio Hetz, Felipe A. Court

CELL DEATH AND DIFFERENTIATION (2020)

Editorial Material Geriatrics & Gerontology

Editorial: Risk Factors for Alzheimer's Disease

Ines Moreno-Gonzalez, Rodrigo Morales, David Baglietto-Vargas, Raquel Sanchez-Varo

FRONTIERS IN AGING NEUROSCIENCE (2020)

Article Multidisciplinary Sciences

Enhancing microtubule stabilization rescues cognitive deficits and ameliorates pathological phenotype in an amyloidogenic Alzheimer's disease model

Juan Jose Fernandez-Valenzuela, Raquel Sanchez-Varo, Clara Munoz-Castro, Vanessa De Castro, Elisabeth Sanchez-Mejias, Victoria Navarroz, Sebastian Jimenez, Cristina Nunez-Diaz, Angela Gomez-Arboledas, Ines Moreno-Gonzalez, Marisa Vizuete, Jose Carlos Davila, Javier Vitorica, Antonia Gutierrez

SCIENTIFIC REPORTS (2020)

Article Biochemistry & Molecular Biology

Requirement of brain interleukin33 for aquaporin4 expression in astrocytes and glymphatic drainage of abnormal tau

Jean Wu, Colin Carlock, Junbo Shim, Ines Moreno-Gonzalez, William Glass, April Ross, Tatiana Barichello, Joao Quevedo, Yahuan Lou

Summary: IL33 is essential for regulating the expression of AQP4 in astrocytes, with its deficiency leading to abnormal tau accumulation in neurons and impaired drainage. This study suggests that different forms of AQP4 play distinct roles in glymphatic drainage, with p-AQP4 driving flow toward perivenous space while n-AQP4 may help remove neuronal wastes. Defects in IL33-related mechanisms may contribute to chronic neurodegeneration and tauopathy in aging mice.

MOLECULAR PSYCHIATRY (2021)

Article Biochemistry & Molecular Biology

Transmission of cerebral amyloid pathology by peripheral administration of misfolded Aβ aggregates

Rodrigo Morales, Javiera Bravo-Alegria, Ines Moreno-Gonzalez, Claudia Duran-Aniotz, Nazaret Gamez, George Edwards, Claudio Soto

Summary: This study demonstrates that administration of Aβ seeds through various peripheral routes can accelerate the accumulation of Aβ in the brains of AD mouse models. Oral administration of brain extracts had no impact on brain pathology. The peripheral administration of Aβ seeds led to the generation of a large proportion of aggregates in blood vessels, suggesting a role of vascular transport in AD-related pathological changes.

MOLECULAR PSYCHIATRY (2021)

Review Clinical Neurology

Animal and Cellular Models of Alzheimer's Disease: Progress, Promise, and Future Approaches

Laura Trujillo-Estrada, Elisabeth Sanchez-Mejias, Raquel Sanchez-Varo, Juan Antonio Garcia-Leon, Cristina Nunez-Diaz, Jose Carlos Davila, Javier Vitorica, Frank M. LaFerla, Ines Moreno-Gonzalez, Antonia Gutierrez, David Baglietto-Vargas

Summary: Alzheimer's disease is an incurable neurodegenerative disease affecting over 45 million people worldwide, with transgenic mouse models playing a significant role in elucidating its pathogenic mechanisms. However, limitations of current animal models highlight the need for more reliable models and human cellular models to improve the success rate of translating preclinical therapies into human treatments.

NEUROSCIENTIST (2022)

Article Neurosciences

Amyloid pathology arrangements in Alzheimer's disease brains modulate in vivo seeding capability

Claudia Duran-Aniotz, Ines Moreno-Gonzalez, Nazaret Gamez, Nelson Perez-Urrutia, Laura Vegas-Gomez, Claudio Soto, Rodrigo Morales

Summary: Diverse patterns of misfolded protein deposition in Alzheimer's disease brains may lead to different phenotypes in recipient mice, suggesting that AD-subtypes are encoded in disease-associated amyloid-beta.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Review Biochemistry & Molecular Biology

Age-related immune alterations and cerebrovascular inflammation

Carson E. Finger, Ines Moreno-Gonzalez, Antonia Gutierrez, Jose Felix Moruno-Manchon, Louise D. McCullough

Summary: Aging is closely associated with chronic systemic inflammation and the development of various age-related diseases, including vascular disease. Poor outcomes after stroke in aged patients are predicted due to altered immune response, which differs from that of younger patients.

MOLECULAR PSYCHIATRY (2022)

Review Cell Biology

Inflammatory Cascade in Alzheimer's Disease Pathogenesis: A Review of Experimental Findings

Jade de Oliveira, Ewa Kucharska, Michelle Lima Garcez, Matheus Scarpatto Rodrigues, Joao Quevedo, Ines Moreno-Gonzalez, Josiane Budni

Summary: Alzheimer's disease is the leading cause of dementia worldwide, with the amyloid cascade hypothesis being the most recognized explanation for AD pathology. The mechanisms underlying late onset AD are not completely clear, with BBB disruption playing an essential role in neuroinflammation and AD development. Systemic inflammation triggered by conditions like metabolic diseases or infections may contribute to the neurodegeneration observed in AD.

CELLS (2021)

Article Medicine, General & Internal

Longitudinal Assessment of Tau-Associated Pathology by 18F-THK5351 PET Imaging: A Histological, Biochemical, and Behavioral Study

Ines Moreno-Gonzalez, George A. Edwards, Omar Hasan, Nazaret Gamez, Jonathan E. Schulz, Juan Jose Fernandez-Valenzuela, Antonia Gutierrez, Claudio Soto, Paul E. Schulz

Summary: This study focused on validating the effectiveness of the PET tracer F-18-THK5351 in detecting early changes in tau-related pathology, showing increased PET signaling over time in transgenic P301S tau mice with positive correlations to histological and biochemical tau changes, as well as motor, memory, and learning impairment. The findings suggest that F-18-THK5351 could be a useful tool in diagnosing tauopathies, understanding their pathophysiologies, and monitoring treatment trials.

DIAGNOSTICS (2021)

Review Biochemistry & Molecular Biology

Transgenic Mouse Models of Alzheimer's Disease: An Integrative Analysis

Raquel Sanchez-Varo, Marina Mejias-Ortega, Juan Jose Fernandez-Valenzuela, Cristina Nunez-Diaz, Laura Caceres-Palomo, Laura Vegas-Gomez, Elisabeth Sanchez-Mejias, Laura Trujillo-Estrada, Juan Antonio Garcia-Leon, Ines Moreno-Gonzalez, Marisa Vizuete, Javier Vitorica, David Baglietto-Vargas, Antonia Gutierrez

Summary: This review provides an overview of the major pathological elements of Alzheimer's disease and discusses the insights provided by mouse models in understanding the underlying mechanisms. It highlights the pros and cons of current models and explores the potential benefits of combining transgenic mice with omics technologies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Preventive and therapeutic reduction of amyloid deposition and behavioral impairments in a model of Alzheimer's disease by whole blood exchange

Akihiko Urayama, Ines Moreno-Gonzalez, Diego Morales-Scheihing, Vineetkumar Kharat, Sandra Pritzkow, Claudio Soto

Summary: Alzheimer's disease is the major form of dementia in the elderly, characterized by neuronal death, synaptic alterations, brain inflammation, and the presence of protein aggregates. Exchanging blood with normal mice can reduce amyloid plaques and improve spatial memory in AD mice, suggesting a potential peripheral target for AD therapy.

MOLECULAR PSYCHIATRY (2022)

No Data Available